Abstract
In 2010, biological medicine industry was identified as strategic new industry. In
the future, China's biological medicine industry will face rapid development. Industry
layout and adjustment will meet great opportunity. At present, China's biological
medicine industry development salient features are: Biological medicine industry in
its early, large investment and cycle is long, the risk is high. It need outside capital
support. At the same time the existing loans financing, equity financing, mergers
restructuring and can't meet the way the development of biological medicine industry
needs. So, as a kind of new financing tools development biological medicine industry
funds have great practical significance.
This paper from the macro environment analysis .Through to the biological
medicine industry and market detailed analysis, find A company investment
opportunities and threats. Then, on A company internal environment are analyzed and
summarized the advantages and disadvantages of company A. Finally, Combined with
4 M pattern on the screening of investment projects and by A company for external,
internal factor evaluation matrix. Puts forward A company growth development
strategy.
This paper investment strategy achievement has reference value to the company
A investment direction and improve investment income.
Key Words: Biological medicine, industry fund, investment strategy